Accellent Inc. Exchange and Registration Rights AgreementExchange and Registration Rights Agreement • February 3rd, 2010 • Accellent Inc • Surgical & medical instruments & apparatus • New York
Accellent Inc., a Maryland corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) an aggregate of $400,000,000 principal amount of its 8 3/8% Senior Secured Notes due 2017, which are guaranteed by the Guarantors identified in the Indenture (as defined herein). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company and the Guarantors agree with the Purchasers for the benefit of holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
CREDIT AGREEMENT Dated as of January 29, 2010 among ACCELLENT INC., as Borrower The Several Lenders from Time to Time Parties Hereto WELLS FARGO CAPITAL FINANCE, LLC as Administrative Agent and Collateral Agent, and WELLS FARGO CAPITAL FINANCE, LLC as...Credit Agreement • February 3rd, 2010 • Accellent Inc • Surgical & medical instruments & apparatus • New York
CREDIT AGREEMENT dated as of January 29, 2010, among ACCELLENT INC., a Maryland corporation (“Borrower”), the lenders from time to time parties hereto (each a “Lender” and, collectively, the “Lenders”), WELLS FARGO CAPITAL FINANCE, LLC, as Administrative Agent and Collateral Agent (such term and each other capitalized term used but not defined in this introductory statement having the meaning provided in Section 1) , and WELLS FARGO CAPITAL FINANCE, LLC, as Lead Arranger and Bookrunner.
